Category: Accesswire

  • Best Clean Methylene Blue Supplement of 2025? Healthletic’s Pharmaceutical Precision Beats the Hype

    Best Clean Methylene Blue Supplement of 2025? Healthletic’s Pharmaceutical Precision Beats the Hype

    How This Data-Driven Compound Is Winning Over Reviewers, Professionals, and Biohackers

    BOSTON, MASSACHUSETTS / ACCESS Newswire / July 17, 2025 / What You’ll Learn

    Best Clean Methylene Blue Supplement
    Best Clean Methylene Blue Supplement

    In 2025, the search for innovative pharmaceutical compounds with adaptive performance properties is accelerating. Among the many contenders, Healthletic has positioned itself prominently in the ongoing conversation around the best methylene blue products on the market. While methylene blue has historically been known for its research-level application in scientific and industrial settings, its role in modern cognitive wellness, mitochondrial efficiency, and cellular support frameworks has now transitioned into mainstream interest. Healthletic has become a leading example of how a pharmaceutical-grade formulation can meet this moment-providing a user-centric, clean-label option that avoids unnecessary hype and prioritizes structural transparency.

    As more consumers seek balance between overstimulation and underperformance, Healthletic fills an emerging gap. It is designed for those experiencing digital burnout, cognitive overload, and general functional fatigue-pressures that have become emblematic of 2025’s fast-paced, screen-saturated culture. Healthletic is not marketed as a cure or quick fix, but as a premium-grade support compound designed with simplicity, clarity, and usability at the forefront. Whether users are digital professionals working long hours, aging adults investing in long-term wellness strategies, or wellness-focused individuals fine-tuning their supplement stack, this product’s structure appeals to a wide demographic that values data-backed integrity over sensationalism.

    In this comprehensive report, readers will explore how Healthletic differs from traditional nootropics or stimulant-based tools, why it consistently appears in expert affiliate breakdowns, how it compares to other pharmaceutical brands in its category, and what structural features make it one of the most trusted methylene blue supplements available today. The article also addresses the science-adjacent logic behind its formulation and identifies what types of individuals are most aligned with Healthletic’s design approach.

    From lifestyle relevance to ingredient transparency, this long-form editorial provides a complete breakdown of why Healthletic is being recognized not only for performance support, but also for its alignment with future-forward consumer values.

    Disclaimer: This article is for informational purposes only. Healthletic products are not intended to diagnose, treat, cure, or prevent any disease. No medical claims are made or implied.

    Section 1: The Growing Importance of Best Methylene Blue in 2025

    The conversation surrounding cognitive clarity, mitochondrial support, and cellular resilience has undergone a significant shift in 2025, particularly among high-functioning individuals confronting the effects of hyper-digital environments. As terms like “digital fatigue,” “information overload,” and “brain fog” become part of everyday vocabulary, more consumers are searching for non-stimulant tools that support focus, energy efficiency, and sustainable wellness from the inside out. Among the compounds gaining traction in this evolving landscape, methylene blue has emerged as a noteworthy candidate-particularly when formulated in pharmaceutical-grade formats like Healthletic.

    Today’s consumers are navigating a convergence of environmental stressors, including artificial lighting, excessive screen exposure, high cognitive demands, and reduced access to deep recovery states. From remote professionals and entrepreneurial multitaskers to aging adults seeking cognitive sustainability, many are looking for alternatives that don’t rely on caffeine, synthetic enhancers, or emotionally stimulating additives. This is where methylene blue-long respected in the scientific world for its redox support mechanisms-has found a new life in the consumer supplement space. But not all methylene blue products are created equal, and this rising awareness is fueling demand for transparency-driven formulations that can be integrated seamlessly into personalized wellness routines.

    The rise of pharmaceutical grade methylene blue is not a passing trend; it’s a response to long-standing gaps in the market. Consumers no longer want scattershot, overloaded supplements that rely on trendy herbs or excessive claims. Instead, they want precision. They want a product that respects the science without overstating it, and one that reflects a shift away from generalist health formulas toward specialized, minimalist compounds that can be tailored to specific support strategies. Healthletic enters this picture as a brand that doesn’t just participate in the methylene blue movement-it helps define it.

    What distinguishes Healthletic in the methylene blue conversation is its clean pharmaceutical backbone. As competing products emerge with flashy branding or exotic ingredient stacks, Healthletic has leaned into restraint. It presents methylene blue as a support tool for today’s real-world cognitive demands, not as a miracle substance. This framing appeals to data-literate users, affiliate reviewers, and health-forward consumers who are increasingly skeptical of over-promised solutions. With a focus on measured delivery, packaging integrity, and ingredient origin validation, Healthletic stands apart as a response to rising demand for structure, not noise.

    As society embraces more ambient wellness practices-such as red light therapy, mindfulness protocols, or low-dose adaptogens-methylene blue is gaining renewed attention as a subtle yet stable option that complements these evolving routines. Healthletic’s rise can be seen in this broader context: it is a modern pharmaceutical product that speaks to the 2025 consumer’s desire for functionality-first support systems that respect user agency, lifestyle variability, and long-term sustainability.

    Readers can Visit the Official Healthletic Site to explore the full report or latest update.

    Section 2: What Is Healthletic and How Is It Structured?

    As the pharmaceutical space continues to evolve in response to consumer demand for clarity, consistency, and high-quality sourcing, Healthletic has emerged as a standout example of how to formulate methylene blue with both scientific discipline and user practicality in mind. At its core, Healthletic is not simply another supplement vying for attention on crowded digital shelves-it is a precisely engineered product designed to meet the modern consumer’s desire for clean-label, minimalist, performance-oriented support. By stripping away the excess often found in multitargeted products and focusing instead on a single, well-understood compound, Healthletic has captured the attention of high-functioning individuals seeking tools that respect their body’s internal rhythm rather than override it.

    The structure of Healthletic is rooted in pharmaceutical principles: purity, stability, and usability. Each bottle of Healthletic is manufactured under cGMP-compliant conditions, ensuring that the methylene blue it contains meets pharmaceutical-grade standards for quality and consistency. The compound itself is delivered in a form that avoids degradation during transit or storage, reflecting attention to shelf stability and packaging integrity. Unlike bulk powders or liquid dropper products that may suffer from oxygen or light exposure, Healthletic’s formulation is optimized for predictable dosing and minimal environmental impact on potency. This type of attention to detail is especially appreciated by bio-conscious users and professionals integrating the compound into structured protocols.

    From a usability standpoint, Healthletic excels where many others falter. The delivery method is tailored for routine use-there is no need for complex measurement tools, secondary solvents, or protective gear. It was designed for frictionless integration into a wellness regimen, without introducing unnecessary cognitive load. This seamlessness is one of the reasons Healthletic has found traction with a wide range of consumers, from longevity-focused individuals to digital creatives managing burnout to athletes exploring mitochondrial resilience without aggressive pharmacological interventions.

    Healthletic is not framed as a cognitive enhancer, energy booster, or miracle solution. Instead, its structural language speaks to sustainability, balance, and function. It avoids vague terms like “detox” or “recharge,” opting instead for language that reflects its intended role as a support tool within a larger framework of personal optimization. Users are not promised transformations-they are offered a consistent, lab-verified compound that they can incorporate into their routines without ambiguity.

    What makes this approach effective is Healthletic’s refusal to overreach. The brand avoids the temptation to pad its formula with synergistic but unverified co-ingredients or turn to exotic additives for marketing flair. Instead, it leans into scientific minimalism-a philosophy that appeals strongly to both first-time researchers and seasoned health practitioners. In doing so, Healthletic delivers on what so many health-minded consumers have been asking for: a transparent, clean, professional-grade methylene blue product that doesn’t require them to be chemists to use it properly.

    Learn More About Healthletic

    Section 3: What Reviewers Are Saying About Healthletic

    In a landscape where product credibility is often built through third-party insights rather than brand narratives, affiliate reviewers have become a powerful force in shaping consumer decisions-particularly within the pharmaceutical and supplement space. Healthletic has consistently earned praise across these review platforms for its clarity of formulation, minimalist philosophy, and usability-first design. Rather than relying on hype, elaborate branding, or controversial biohacking claims, Healthletic is recognized for what it avoids just as much as for what it includes. This restraint, far from being seen as a weakness, has become one of its most lauded strengths in affiliate and expert reviews.

    One of the most common themes in Healthletic reviews is the appreciation for its clean-label positioning. In contrast to some methylene blue products that attempt to broaden their appeal with multi-compound blends or synthetic enhancers, Healthletic sticks to its core. Reviewers note that this single-focus design allows users to evaluate the compound’s effects more reliably-without the confusion introduced by layering multiple active ingredients. This clarity is essential not just for beginners, but also for seasoned users who want to incorporate methylene blue into larger protocols involving light exposure therapy, nootropic stacking, or long-term cellular health strategies.

    Another repeated observation among affiliate reviewers is the brand’s compatibility with modern lifestyles. Healthletic doesn’t try to dominate a user’s routine-it fits into it. Its ease of use, professional packaging, and stable formulation eliminate the friction that might otherwise discourage consistent use. For example, busy professionals, digital creatives, and even fitness enthusiasts mention how Healthletic’s structure allows them to maintain daily routines without adjusting schedules or introducing new prep rituals. Its simplicity translates directly to increased adoption, and that adoption supports more accurate self-assessment over time.

    Moreover, reviewers appreciate the way Healthletic communicates. Rather than relying on speculative science or borderline claims, the brand focuses on being a dependable support option. Affiliate writers often reference how Healthletic avoids the aggressive sales language used by other companies in the space-especially those promising “rapid neuro regeneration” or “instant mental breakthroughs.” Instead, Healthletic is described as stable, transparent, and compatible with a long-term view of wellness. For users who are already skeptical of overstated product marketing, this tone offers a refreshing change and builds trust through consistency.

    It’s also worth noting how Healthletic is discussed within competitive ranking lists. When methylene blue products are compared side by side on platforms that evaluate supplement performance, ingredient traceability, and long-term safety considerations, Healthletic is consistently featured in the upper tier. The absence of stimulants, artificial coloring, or flavoring agents positions it favorably among the clean-label crowd-while its pharmaceutical manufacturing standards ensure it can be evaluated against more technically demanding criteria.

    Reviewers also highlight the neutral branding and professional-grade appearance of Healthletic. In a market full of flashy logos, exaggerated product names, and influencer-driven testimonials, Healthletic presents itself with restraint and intention. This appeals not only to medical-adjacent users and research-inclined individuals but also to everyday consumers who want something functional without the feel of over-marketed lifestyle promises.

    Read the Expert Breakdown of Healthletic

    Section 4: Comparing Healthletic to Competitors in the Pharmaceutical Space

    The competitive landscape for methylene blue in the pharmaceutical supplement category has grown increasingly dense in 2025, as more brands attempt to capitalize on consumer interest in mitochondrial support, cognitive function, and long-term wellness. However, the influx of options has revealed significant variation in formulation philosophy, ingredient sourcing, user experience, and transparency. In this landscape, Healthletic has emerged not just as a viable option-but as a category leader among pharmaceutical-grade methylene blue supplements. A closer comparison with its competitors shows exactly why it consistently earns that position.

    One of the most distinct differences between Healthletic and its peers lies in its ingredient logic. Many methylene blue products on the market today are marketed under flashy names and bundled with secondary compounds in an effort to create a “synergistic” profile. While this strategy can sound compelling on the surface, it introduces complexity and potential unknowns, particularly when ingredient interactions are not fully studied or when the purity levels are not clearly disclosed. Healthletic’s approach stands in direct contrast-it provides a single-focus methylene blue formulation with verifiable purity and traceable sourcing, eliminating ambiguity for the end user.

    This commitment to transparency is another defining factor. Competitor products often use proprietary blends or list methylene blue as part of a vague “complex,” making it difficult for consumers to determine exact dosages, origins, or stability. Healthletic, on the other hand, publishes clear formulation specifications, adheres to pharmaceutical manufacturing protocols, and discloses the concentration and grade of methylene blue used. For researchers, health practitioners, and precision-driven consumers, this level of disclosure isn’t just a perk-it’s a prerequisite.

    From a usability perspective, Healthletic also shines. Many competing products still rely on unstable liquid delivery systems, poorly labeled droppers, or unbuffered powders that degrade rapidly when exposed to light or air. This leads to inconsistent dosing and unnecessary waste, especially for those new to working with the compound. Healthletic overcomes these challenges through optimized storage protection, pre-measured delivery systems, and long-shelf-life engineering. For busy professionals, this means less time managing or troubleshooting their supplement use and more time benefiting from its support role.

    Another important competitive dimension is Healthletic’s stimulant-free design. Whereas some competitors embed methylene blue in energy-focused stacks or combine it with caffeine derivatives, synthetic nootropics, or herbal activators, Healthletic maintains a neutral profile. It provides foundational support without pushing the nervous system into overdrive. For users prone to overstimulation, burnout, or anxious responses to aggressive formulations, this minimalist structure makes Healthletic an attractive alternative.

    Brand culture and communication style also set Healthletic apart. In a space where marketing hype often overtakes substance, Healthletic’s voice remains measured, focused, and data-conscious. Its packaging avoids exaggerated terminology. Its product descriptions lean into function rather than fantasy. This quiet confidence has made it a preferred recommendation among reviewers seeking products that support wellness without triggering false expectations or dependency on subjective claims.

    Finally, Healthletic’s manufacturing infrastructure matches or exceeds most of its competitors. While many brands operate in supplement-grade environments that allow looser tolerance for impurities or inconsistencies, Healthletic chooses pharmaceutical standards-ensuring a higher level of consistency, safety, and trust. For those integrating methylene blue into performance routines, research-informed self-care plans, or long-term vitality strategies, this difference in production quality is more than just technical-it’s meaningful.

    Discover the Structure Behind Pharmaceutical Supplements

    Section 5: Deeper Look at Healthletic’s Ingredient or Feature Philosophy

    In the realm of high-integrity pharmaceutical supplements, ingredient philosophy often tells a deeper story than a product label or marketing claim. With Healthletic, the design philosophy goes beyond ingredient inclusion-it reflects a commitment to clinical-grade simplicity, system compatibility, and performance neutrality. While many supplement companies try to differentiate themselves by adding more compounds, more synergizers, or more lifestyle-themed enhancements, Healthletic takes the opposite approach. Its philosophy is rooted in subtraction, not addition. This deliberate restraint has made it a favorite among consumers looking to reduce supplement noise and focus on outcomes they can reliably observe and evaluate.

    At the core of Healthletic’s structure is a highly purified, pharmaceutical-grade methylene blue. Sourced from verified, contamination-free suppliers, the compound undergoes rigorous testing to meet USP (United States Pharmacopeia) standards. This level of purity matters significantly-not only for safety and consistency but also for the compound’s ability to perform its cellular redox functions without interference. Contaminants or unverified grades can disrupt the delicate oxidative balance methylene blue is known to influence. By ensuring purity at the molecular level, Healthletic provides users with the confidence that every dose is biochemically stable, predictable, and bioavailable.

    Bioavailability itself is another core feature in Healthletic’s philosophy. The compound is delivered in a carrier format designed to ensure consistent absorption without requiring co-administration with emulsifiers, fatty acids, or synthetic excipients. Unlike competitor products that rely on high-volume dosing or unstable suspension solutions, Healthletic delivers an effective amount of methylene blue in a way that respects both gut transit and light-oxygen degradation variables. This matters to professionals and health-conscious users who want real-world performance from their investment-not just theoretical claims.

    Another central tenet is structural minimalism. Healthletic contains no filler compounds, sweeteners, dyes, preservatives, or binding agents that could interfere with the function of the methylene blue itself. In this sense, the product operates with surgical precision-it delivers what the user expects and nothing more. This makes it uniquely compatible with both solo use and larger, multifaceted wellness regimens. For example, those using red light therapy, ketone management tools, or polyphenol protocols find that Healthletic’s simplicity reduces the need for dosage conflict troubleshooting or ingredient cross-checking.

    Fourth, Healthletic adheres to what could be described as a philosophy of cognitive neutrality. Unlike many compounds that stimulate or sedate, methylene blue in its pharmaceutical form offers a rare profile: it supports mitochondrial performance and redox balance without introducing artificial mood or energy shifts. Healthletic preserves this balance by ensuring the methylene blue is free from companion compounds that might disrupt focus or overstimulate the nervous system. This neutrality allows users to track their response to the compound more accurately and adjust routines with clarity.

    Fifth, and perhaps most importantly, Healthletic reflects a growing trend in the self-care and wellness market: the desire for tools that empower rather than dictate. The product is not framed as a miracle, cure, or shortcut. Instead, it’s positioned as a modular compound that allows users to design their own performance frameworks. Whether the goal is neuroprotection, endurance optimization, or cellular resilience, Healthletic gives users a stable platform from which to build. This speaks to a maturing consumer mindset-one that is no longer chasing magic pills but investing in long-term systems thinking.

    Explore the Pharmaceutical Reviews for Healthletic

    ection 6: How Affiliate Reviewers Rate Healthletic

    Affiliate reviewers play an essential role in guiding consumers through the crowded marketplace of wellness supplements and pharmaceutical compounds, particularly those like methylene blue that straddle the line between scientific heritage and modern self-care application. In 2025, Healthletic has become a recurring presence across expert review lists, biohacker roundups, and clean-label comparison charts-not because it dominates through flashy marketing or price positioning, but because it consistently meets the evaluation criteria that matter most to informed buyers. Through hundreds of affiliate reviews and long-form product breakdowns, Healthletic has become a top-rated option for those looking to incorporate methylene blue into a sustainable performance-support protocol.

    One of the main reasons Healthletic is rated so highly is its precision-driven design. Reviewers often highlight the brand’s decision to focus solely on pharmaceutical-grade methylene blue rather than combining it with herbal extracts, artificial carriers, or trend-based enhancements. This concentrated formulation makes it easier for reviewers to evaluate Healthletic on its own terms. They are able to assess purity, consistency, and usability without the confounding variables introduced by multi-ingredient stacks. In technical reviews where objectivity and testing clarity matter, this streamlined profile consistently works in Healthletic’s favor.

    Usability is another area where Healthletic earns top marks. In review articles that focus on real-world application, reviewers emphasize the convenience and low-maintenance nature of the product. It does not require refrigeration, complicated dosing calculations, or laboratory-style preparation methods-issues that continue to plague competing methylene blue products. Instead, Healthletic offers a straightforward, stable solution that integrates easily into a consumer’s daily rhythm. Affiliate reviewers have noted that this simplicity encourages long-term adherence, which is a critical factor when assessing the value and utility of any pharmaceutical-grade supplement.

    Healthletic also receives praise for its non-aggressive marketing and packaging tone. While some competitors use hyperbolic claims or visual branding that leans into exaggerated results, Healthletic maintains a clinical and composed voice across its product pages and marketing materials. Reviewers have pointed out that this language-void of urgency, miracle narratives, or pushy upselling-builds trust with discerning consumers. For those who rely on affiliate breakdowns to make informed decisions, a brand’s tone and transparency often weigh just as heavily as its ingredient list.

    In list-based rankings-such as “Top Methylene Blue Supplements for Focus and Energy” or “Best Pharmaceutical Compounds for Cellular Optimization”-Healthletic frequently appears within the top three. Notably, these lists often place emphasis on manufacturing standards, third-party testing, clean-label formulation, and brand integrity. Healthletic’s use of cGMP-certified facilities, batch-level purity testing, and stability-focused delivery formats meets or exceeds the criteria that affiliate editors use to vet products before recommendation.

    Moreover, reviewers appreciate Healthletic’s compatibility with other wellness strategies. Its stimulant-free, single-compound formula makes it ideal for stacking alongside practices such as intermittent fasting, low-light therapy, or neurofeedback training-without the risk of overstimulation or ingredient interaction. This functional flexibility is often highlighted in affiliate blogs that aim to help readers construct personalized, modular health stacks.

    Finally, affiliate reviewers frequently cite consumer feedback as part of their rating logic. Healthletic has amassed a reputation for low complaint volume, high reorder rates, and consistent delivery experiences-important metrics for those writing about products not just from a scientific angle but also from a user satisfaction standpoint. It’s this blend of structural integrity, user-oriented design, and calm confidence that makes Healthletic stand out in an otherwise noisy category.

    See Why Healthletic Was Ranked Among the Best

    Section 7: The Science or Technical Framework Behind Pharmaceutical Methylene Blue

    In 2025, the renewed interest in methylene blue is grounded not in trend-based excitement, but in the compound’s longstanding reputation as a redox-active agent with reliable behavior at the cellular level. While Healthletic avoids marketing its product as a treatment or therapeutic intervention, the scientific logic behind its formulation still resonates with users seeking well-structured tools for wellness and cognitive performance support. To understand Healthletic’s positioning in the pharmaceutical space, it’s important to look beyond consumer trends and into the foundational frameworks that make pharmaceutical methylene blue appealing to researchers, health analysts, and educated users alike.

    At the core of Healthletic’s value proposition is its relationship with the mitochondrial electron transport chain-an area of increasing focus among those exploring the biological roots of fatigue, cognitive clarity, and aging. Methylene blue has been referenced in numerous peer-reviewed contexts as a compound capable of supporting redox balance and aiding in the efficient transfer of electrons within the mitochondrial network. What makes Healthletic’s approach unique is not a new discovery, but a more accessible application of this framework, made available in a format suitable for consumer use without compromising on stability or pharmaceutical purity.

    The technical design behind Healthletic also acknowledges the challenges associated with methylene blue’s chemical behavior. The compound is highly light-sensitive, susceptible to oxidative degradation, and prone to instability in poorly managed formulations. Many commercially available methylene blue products fail to address these issues, resulting in rapid potency loss or inconsistent absorption. Healthletic’s pharmaceutical manufacturing practices are engineered to eliminate these failure points. Its packaging is designed to minimize exposure to light and oxygen, while the delivery format is calibrated to offer consistent usability without requiring refrigeration, secondary solvents, or constant remeasurement.

    Another important layer in Healthletic’s science-adjacent framework is its focus on dose discipline. Whereas some products fluctuate between subtherapeutic and excessive concentrations, Healthletic maintains a consistent, research-informed dose structure that prioritizes safety and reliability. This aligns with the preferences of consumers who are looking to evaluate a compound’s effects over time-not chase sensationalized outcomes. The ability to integrate a consistent, well-calibrated methylene blue product into a larger optimization or wellness plan is something that both researchers and experienced self-trackers have come to appreciate.

    Healthletic also fits well into broader conversations about neuroprotection, metabolic resilience, and cellular repair-all areas where methylene blue has been explored under formal scientific inquiry. While Healthletic makes no direct claims about these functions, its formulation decisions clearly reflect an awareness of these study areas. For example, Healthletic avoids additives or buffering agents that could interfere with mitochondrial processing, ensuring the compound remains biochemically available for its intended support role. This thoughtful omission is just as important as the ingredients that are included, especially for users who are designing stacks based on pathways like NAD+ production, ATP output, or oxidative defense.

    Feedback from technically-minded consumers and product analysts reinforces the notion that Healthletic is more than just a retail product-it’s a product built with scientific literacy in mind. Reviewers often highlight how the brand strikes a balance between professional-grade detail and accessible presentation. This allows Healthletic to serve both as a stand-alone support compound and as part of a larger bio-optimization or cognitive longevity protocol.

    Lastly, the compound’s compatibility with other data-driven wellness tools-such as low-level light therapy, wearable cognitive monitoring devices, or oxygen utilization tracking-positions it at the forefront of a new generation of supplements that are not just consumed, but integrated. Healthletic makes it easy to do just that by preserving the scientific utility of methylene blue while presenting it in a format that respects consumer autonomy, lifestyle variability, and self-regulation priorities.

    Learn More About Healthletic

    Section 8: Who Might Consider Trying Healthletic

    The modern wellness consumer has evolved far beyond the one-size-fits-all supplement buyer. In 2025, the individuals most aligned with pharmaceutical-grade compounds like Healthletic are those who value precision, clarity, and compatibility in their performance-support routines. These are not impulse buyers-they are thoughtful users who often arrive at methylene blue after weeks or months of research, comparison, and cross-referencing with emerging scientific findings. Healthletic’s design, tone, and formulation strategy make it particularly appealing to several distinct user profiles who prioritize sustainability over sensationalism and structure over stimulation.

    One prominent demographic includes high-performing professionals-those who navigate cognitively intense environments and are looking for ways to maintain mental sharpness without relying on traditional stimulants. These users may be entrepreneurs, software developers, designers, analysts, or content creators who experience digital fatigue, context-switching stress, and the cumulative toll of multitasking. Healthletic’s methylene blue formulation offers a supportive tool that integrates into their routine without disrupting focus or energy flow, making it especially valuable for those avoiding caffeine-based nootropics or emotionally arousing supplements.

    Another group drawn to Healthletic consists of longevity-minded individuals. These users tend to follow developments in mitochondrial health, oxidative stress management, and cellular repair. Many are familiar with redox biology, fasting-mimicking diets, circadian optimization, and the role of mitochondrial efficiency in long-term cognitive performance. Healthletic speaks their language by offering a clean, single-compound format that allows for controlled experimentation, protocol integration, and self-monitoring. It avoids the fluff and “anti-aging” marketing tropes and instead delivers a product that aligns with their desire for consistent, measured support.

    A third profile includes health practitioners and wellness coaches seeking reliable tools to recommend within structured, patient-aligned programs. Because Healthletic adheres to pharmaceutical-grade standards and publishes its purity benchmarks, it is easier for professionals to assess its place in broader protocols. Its stimulant-free profile, clearly stated dose, and minimal risk of interaction make it a more approachable option for inclusion in foundational support regimens or cognitive protection strategies. Additionally, its stability and straightforward storage requirements make it an ideal choice for programs requiring consistency and minimal variability.

    Healthletic is also attracting attention from the recovery and resilience community-individuals dealing with burnout, neurofatigue, or long-COVID-like post-viral symptoms (without suggesting treatment). These users often research mitochondrial dysfunction and explore options that support metabolic and neurological equilibrium. Healthletic’s clean-label design makes it an attractive candidate for this audience, who may already be cautious about supplement overload and are seeking low-risk, observational entry points into redox-focused support compounds.

    Another compelling subset of users includes self-optimizers, quantified-self participants, and biofeedback enthusiasts. These individuals use wearable technology, biometric tracking, and personalized dashboards to monitor performance and adapt their protocols based on real-time data. Healthletic appeals to them because of its simplicity-it doesn’t complicate their stacks, doesn’t skew sleep cycles or heart rate variability, and doesn’t introduce unpredictable variables. It functions as a steady, testable input in a highly controlled optimization environment.

    And finally, there is a large cohort of quiet consumers-people who do not follow wellness influencers or biohacking trends but who want reliable support tools that don’t come with hype or complexity. These users may have experienced disappointment with traditional energy supplements or mental clarity boosters and are seeking something calmer, more focused, and rooted in scientific tradition. Healthletic offers an approachable, neutral formulation that can be taken with confidence by those who prefer subtle results over dramatic claims.

    See Full Comparison at Official Website

    Section 9: Questions Consumers Frequently Ask About Healthletic

    In 2025, as the demand for clean-label pharmaceutical supplements grows, so does the curiosity around how products like Healthletic function within a daily wellness routine. Consumers navigating cognitive fatigue, bio-optimization strategies, or longevity-focused self-care often have nuanced, practical questions that go beyond traditional FAQs. Healthletic, known for its transparency and usability, has inspired a unique category of inquiries from prospective and returning users alike. Below are some of the most frequently asked questions, answered in paragraph format to reflect the deeper level of consideration today’s supplement buyers apply before incorporating a product into their lives.

    One of the most common questions is how often Healthletic can be taken and what daily use looks like. Users typically want to understand how methylene blue fits into structured routines, whether it’s during periods of high cognitive demand, physical recovery, or as part of a baseline wellness approach. Healthletic is designed for consistent, measured use and is formulated to support integration into daily rituals without requiring complex timing windows or secondary supplementation. Consumers are advised to follow usage guidelines based on their personal goals and always observe their response over time to make informed adjustments.

    Another frequent area of inquiry is compatibility-whether Healthletic can be used alongside other products or protocols without causing disruption. Many users of Healthletic also engage in functional wellness practices such as red light therapy, intermittent fasting, creatine supplementation, or polyphenol cycling. Because Healthletic is a single-compound, stimulant-free formulation, it is commonly regarded as flexible within a stack. It does not contain aggressive synergizers or herbal extracts that could interfere with other compounds, making it easier to monitor individual product performance over time.

    Consumers also want to know what to expect in terms of timeline-when and how subtle effects might emerge, and how they should interpret changes in clarity, stamina, or general resilience. Healthletic does not produce immediate or dramatic effects, which aligns with the expectations of users who prefer gradual, measurable shifts. Rather than delivering a “kick” or energy spike, the product is often described in reviews as contributing to a background layer of consistency, particularly for users engaged in long-term vitality strategies. While everyone’s response may differ, most affiliate reviewers recommend at least a two- to four-week window of consistent use before evaluating outcomes.

    Storage and portability are also practical considerations, especially among travelers or those with mobile work routines. Consumers often ask if Healthletic needs refrigeration, if it’s light-sensitive, or if it can withstand temperature changes during transport. The product is formulated with pharmaceutical-grade integrity and packaged to resist degradation from light and oxygen exposure. This makes it suitable for shelf-stable storage and convenient for those who maintain wellness routines across workspaces, co-working hubs, or during travel.

    New users also frequently ask if Healthletic causes noticeable stimulation, fatigue, or mood shifts. This question usually stems from concerns about products that induce jitteriness, drowsiness, or mood imbalance. Because Healthletic contains no central nervous system stimulants or sedatives, it maintains a neutral profile. Users often report that the product “stays in the background,” supporting performance without triggering dramatic shifts in physical or emotional state. This quality is one of the most cited reasons why consumers choose Healthletic over methylene blue options that are paired with caffeine, L-theanine, or other activating compounds.

    Another question arises around the brand’s sourcing and testing transparency-how Healthletic verifies purity and consistency batch to batch. Consumers are increasingly skeptical of vague marketing claims and want assurance that what they are taking has been validated independently. Healthletic addresses this by manufacturing in cGMP-certified facilities, publishing detailed quality control data, and using third-party testing to confirm the absence of contaminants. This information is readily available to reviewers and customers, reinforcing the brand’s reputation as a trustworthy supplier in the pharmaceutical-grade wellness space.

    Finally, many consumers wonder if Healthletic is appropriate for people who are new to bio-optimization or pharmaceutical support compounds. In this regard, Healthletic’s formulation makes it an excellent entry point. Its clarity, simplicity, and measured delivery eliminate the learning curve often associated with research-backed supplements. New users do not need to modify their routines dramatically or develop new tracking systems to benefit from the product. Instead, they can begin with confidence, knowing they are using a product designed for structure, not spectacle.

    Explore the Pharmaceutical Reviews for Healthletic

    Section 10: Why Healthletic Fits the 2025 Innovation Model

    In the evolving landscape of personal wellness and pharmaceutical-grade supplementation, 2025 has marked a clear shift in how consumers evaluate innovation. No longer swayed by flashy ingredient stacks, bold marketing, or short-term performance hype, today’s health-focused individuals are prioritizing longevity, structural transparency, and product functionality above all. In this new framework, Healthletic has emerged as a flagship example of what true innovation looks like-simple in design, grounded in science, and refined for the needs of discerning users who expect their supplements to be as intentional as the rest of their wellness routine.

    Healthletic’s formulation exemplifies the core traits of modern product innovation: focus, restraint, and clean utility. It represents a growing category of compounds that are not invented for novelty but repurposed from decades of scientific insight and refined for user safety and precision. Methylene blue, while not new to clinical literature, is undergoing a reinvention as more consumers look for lifestyle-aligned ways to support cognitive function, cellular efficiency, and metabolic integrity without overstimulation. Healthletic is not the only brand offering this compound-but it is one of the few doing so with pharmaceutical integrity and a lifestyle-conscious approach.

    This alignment with next-generation consumer values-especially those in the longevity and cognitive performance spaces-is not accidental. Healthletic’s design decisions reflect a deep understanding of today’s bio-aware buyer. The brand does not position itself as a disruptor in the loud, marketing-driven sense. Instead, it acts as a stabilizer-offering consistency in a chaotic supplement market, trust in an era of skepticism, and a sense of control to users who want to build long-term systems for mental clarity and physical resilience.

    In terms of macro wellness trends, Healthletic dovetails with the increasing demand for products that serve functional aging, support emotional bandwidth in high-performance roles, and reduce the cognitive load of daily supplementation. Many users today seek ways to maintain their output without compromising their long-term health, and Healthletic’s single-ingredient profile speaks to this beautifully. It doesn’t compete with complex stacks or crossover products-it complements them, offering a foundational layer of support that doesn’t require second-guessing or extensive research to use effectively.

    Healthletic also fits into the broader conversation around sustainability-not just environmental, but behavioral. Supplements that require cycling, adaptation, or invasive scheduling can be hard to maintain. Healthletic, by contrast, is designed for consistency. Its formulation does not tax the body, conflict with baseline habits, or create rollercoaster effects that require careful recovery. This makes it an ideal addition to the new class of self-regulation tools that empower users to take health into their own hands-quietly, confidently, and over time.

    Finally, as the supplement industry becomes more regulated and consumers become more educated, brands that fail to show their work-via transparent sourcing, independent testing, or clean manufacturing-are losing ground. Healthletic’s adherence to cGMP production, third-party batch testing, and openly published ingredient data shows that innovation isn’t just about what’s inside the bottle-it’s about how a product earns and maintains user trust across multiple touchpoints.

    See Why Healthletic Was Ranked Among the Best

    Contact Information

    • Healthletic

    • Email: hello@healthletic.io

    YMYL Disclaimer
    The content provided in this article is intended for general informational and educational purposes only. It does not constitute professional advice, diagnosis, or treatment, and should not be used as a substitute for consultation with a qualified healthcare or medical professional. The subject matter discussed may involve health-related decisions, and readers are encouraged to consult their physician or licensed provider before starting any new supplement, pharmaceutical, or lifestyle regimen. Neither the publisher nor the author assumes any responsibility for actions taken based on the information provided in this publication.

    FDA Disclaimer
    Statements made in this article regarding Healthletic or methylene blue have not been evaluated by the U.S. Food and Drug Administration (FDA). Products discussed are not intended to diagnose, treat, cure, or prevent any disease. All references to effects, mechanisms, or benefits are for informational purposes only and reflect general consumer use trends, affiliate reviews, or theoretical frameworks, not clinical outcomes. Individual experiences may vary. Use only as directed and consult a licensed medical professional before use, especially if pregnant, nursing, taking medication, or being treated for any medical condition.

    Contact Information

    Healthletic Customer Support
    hello@healthletic.io

    .

    SOURCE: Healthletic

    View the original press release on ACCESS Newswire

  • 1933 Industries Reminds Shareholders to Vote at the Upcoming Annual General Meeting

    1933 Industries Reminds Shareholders to Vote at the Upcoming Annual General Meeting

    VANCOUVER, BC / ACCESS Newswire / July 17, 2025 / 1933 Industries Inc. (the “Company” or “1933 Industries”) (CSE:TGIF)(OTC PINK:TGIFF), a Nevada-focused cannabis cultivator and producer, reminds shareholders to vote at the Annual General Meeting (the “AGM“) to be held on July 25, 2025 at 10:30 a.m. (Vancouver time).

    The deadline to receive all votes/proxies is 10:30 a.m. (PST) on Wednesday, July 23, 2025. The Company reminds all Shareholders to submit their proxies before the deadline.

    Shareholders will be asked to vote on the following matters:

    1. To receive the audited consolidated financial statements of the Company for the fiscal year ended July 31, 2024

    2. To set the number of directors to be elected at the AGM at Three (3)

    3. To elect directors

    4. To appoint MNP LLP, Chartered Professional Accountants as Auditors of the Company for the ensuing year and to authorize the Directors to fix their remuneration

    5. To consider a resolution approving unallocated options under the Company’s existing Stock Option Plan until July 25, 2028

    6. To consider by ordinary resolution, the amendment of the Articles of the Company

    The details of all matters proposed to be put before the shareholders at the AGM are set forth in the Management Information Circular (the “Circular“). Shareholders are reminded to view the Circular prior to voting. Materials for the Meeting may be viewed online at:

    1933industries.com/investors/agm-materials

    www.sedar.com

    Meeting Date and Location

    Date & Time: Friday, July 25, 2025 at 10:30 a.m. (PST)

    Place: Boardroom of Suite 300 – 1055 West Hastings Street, Vancouver, BC, V6E 2E9

    Record Date: Only shareholders of record at the close of business on June 10, 2025, (the “Record Date“) are entitled to vote at the meeting or any adjournment or postponement thereof.

    All shareholders are entitled to attend the AGM and vote by proxy. No voting is permitted on the day of the meeting.

    Voting

    Registered shareholders of Record Date are asked to return their proxies using one of the following methods by the proxy cut-off date (10:30 a.m. PST, July 23, 2025).

    • INTERNET: https://vote.odysseytrust.com

    • MAIL: Proxy Department, Odyssey Trust Company, Trader’s Bank Building, 702, 67 Yonge Street, Toronto Ontario M5E 1J8.

    Non-registered holders are asked to use the voter instruction form provided by your intermediary (bank, trust company or broker) and return it as early as practicable to ensure that it is transmitted on time. It must be received by your intermediary with sufficient time for them to file a proxy by the deadline noted above. Shareholders with questions about notice-and-access can call Odyssey Trust toll free at 1-888-290-1175 or proxy@odysseytrust.com

    About 1933 Industries Inc.

    1933 Industries is a Nevada-based licensed producer, focused on the cultivation and extraction of a large portfolio of cannabis consumer products in a variety of formats under its flagship brands, Alternative Medicine Association (AMA) and Level X. Its product offerings are cultivated at the Company’s 68,000 sq. ft. indoor facility and marketed directly to retail dispensaries. AMA branded flower, infused pre-rolls, and in-house boutique concentrates consistently rank as the top products sold in Nevada. For more information, please visit www.1933industries.com

    For further information please contact:
    Alexia Helgason, VP, Investor Relations
    604-728-4407
    alexia@1933industries.com

    Brian Farrell, Chairman and CEO
    brian@1933industries.com

    Neither the Canadian Securities Exchange nor its Regulation Services Provider (as that term is defined in the policies of the Canadian Securities Exchange) accepts responsibility for the adequacy or accuracy of this release.

    Notice regarding Forward Looking Statements: This news release contains forward-looking statements. The use of any of the words “anticipate”, “continue”, “estimate”, “expect”, “may”, “will”, “project”, “should”, “believe” and similar expressions are intended to identify forward-looking statements. Although the Company believes that the expectations and assumptions on which the forward-looking statements are based are reasonable, undue reliance should not be placed on the forward-looking statements because the Company can give no assurance that they will prove to be correct. Since forward-looking statements address future events and conditions, by their very nature they involve inherent risks and uncertainties. These statements speak only as of the date of this news release. Actual results could differ materially from those currently anticipated due to a number of factors and risks including various risk factors discussed in the Company’s disclosure documents, which can be found under the Company’s profile on www.sedar.com. 1933 Industries undertakes no obligation to update publicly or revise any forward-looking information, whether as a result of new information, future events or otherwise, except as required by law.

    SOURCE: 1933 Industries Inc.

    View the original press release on ACCESS Newswire

  • GPOPlus+ to Present Growth Strategy at Liberty Ventures Investor Summit in Chicago

    GPOPlus+ to Present Growth Strategy at Liberty Ventures Investor Summit in Chicago

    CEO Brett H. Pojunis to Highlight Expansion, Profitability Gains, and Vision to Scale to 20,000+ National Retail Partners

    LAS VEGAS, NEVADA / ACCESS Newswire / July 17, 2025 / GPO Plus, Inc. (OTCQB:GPOX), an AI-powered Distributor revolutionizing distribution to gas stations and convenience stores with its innovative technology-driven Direct Store Delivery (DSD) model, today announced that CEO Brett H. Pojunis will present at the Liberty Ventures Investor Summitin Chicago on Monday, July 21, 2025.

    The Liberty Ventures Investor Summit is an exclusive gathering of accredited investors, fund managers, and founders. The Summit is a one-day event focused on connecting capital with high-impact ventures, fostering principled deal flow, and equipping investors with tools to scale freedom through business. For those interested in attending or learning more about the event, please visit:

    By presenting at the Liberty Ventures Investor Summit, GPOX aims to connect with values-aligned investors to support its mission: to build the largest and most efficient DSD network, servicing independent retailers across the U.S.

    Mr. Pojunis will outline GPOX’s accelerated growth strategy, key milestones, and the Company’s roadmap to scale nationally. The presentation will expand on GPOX’s recent June 2025 Shareholder Update, highlighting:

    • New Call Center: Operational with an experienced manager and inside sales team to drive nationwide B2B sales.

    • Field Sales Deployment: The first “G-FORCE” team has been activated, targeting over 200 new stores, with plans to replicate this model in new markets.

    • AI-Driven Wholesale Portal: Real-time ordering platform supporting both DSD and new “DISTRO+ Cash + Carry” locations.

    • Upgraded Regional Hubs: New climate-controlled warehouses expanding SKU offerings and market capacity.

    GPOX is laser-focused on aggressive revenue growth,” said Pojunis. “We’re executing a proven model, consistently exceeding targets, optimizing operations, and building a national footprint, and this is just the beginning.”

    Pojunis will emphasize GPOX’s transition from building its DSD infrastructure to entering full-scale expansion, with new sales channels and technology initiatives now live.

    GPOX has proven its model, reporting an 87% increase in gross margins, from 15% to 28%, and an 11% YTD increase in revenues, signaling strong operational traction as it scales.

    Alexander McCobin, CEO of Liberty Ventures, commented: “We’ve been closely watching GPOX over the past year, and the progress they’ve made is nothing short of remarkable. From building out their infrastructure to launching new revenue channels and tightening operational execution, GPOX has demonstrated what it means to scale with purpose. They’ve transitioned from a developmental stage startup to a serious, growth-oriented enterprise that aligns with the kind of visionary companies we champion at Liberty Ventures.”

    For more information, visitwww.GPOPlus.com


    Connect with us on social media to view live video updates, content, and general information about GPOX: https://gpoplus.com/social.


    About GPOPlus+ (GPOX)

    GPOX is an AI-powered Distributor revolutionizing the future of distribution to gas stations and convenience stores with its innovative technology-driven Direct Store Delivery (DSD) model. Our goal is clear and ambitious: “to build the largest nationwide DSD distribution company servicing gas stations, convenience stores, and beyond.” Our technology-driven AI network, featuring strategically placed Regional Hubs and Mini Hubs, is designed to optimize efficiency and maximize reach. Central to our operations is our in-house AI technology platform, PRISM+. Designed to streamline the distribution process, PRISM+ supports efficient delivery, inventory management, data analytics, and overall operational excellence, enabling us to reliably and effectively meet the dynamic needs of our partners. Our mission is to consolidate the fragmented market segment managed by numerous regional vendors. Our dedication to excellence is evident in our product selection process, where we align offerings with consumer demand and partner with top-tier vendors and brands, ensuring our portfolio remains diverse and highly profitable. For more information, please visit www.GPOPlus.com.


    About Liberty Ventures

    An ecosystem of purpose-driven investors and entrepreneurs aligned on advancing a free and prosperous future. Liberty Ventures helps like-valued business leaders work with each other to scale the impact of their business and their leadership. Visit libertyventures.xyz to learn more and get involved!


    Information about Forward-Looking Statements

    This press release contains “forward-looking statements” that include statements regarding expected financial performance and growth information relating to future events. Forward-looking statements include statements with respect to beliefs, plans, objectives, goals, expectations, anticipations, assumptions, estimates, intentions, and future performance, and involve known and unknown risks, uncertainties and other factors, which may be beyond the control of the Company and its officers and managers, and which may cause actual results, performance or achievements to be materially different from future results, performance or achievements expressed or implied by such forward-looking statements. Forward-looking statements should not be read as a guarantee of future performance or results and will not necessarily be accurate indications of the times at, or by which, that performance or those results will be achieved. Forward-looking statements are based on information available at the time they are made and/or management’s good faith belief as of that time with respect to future events and are subject to risks and uncertainties that could cause actual performance or results to differ materially from those expressed in, or suggested by, the forward-looking statements. Important factors that could cause these differences include, but are not limited to; inability to gain or maintain licenses, reliance on unaudited statements, the Company’s need for additional funding, governmental regulation of the cannabis industry, the impact of competitive products and pricing, the demand for the Company’s products, and other risks that are detailed from time-to-time in the Company’s filings with the United States Securities and Exchange Commission. All statements other than statements of historical fact are statements that could be forward-looking statements. You can typically identify these forward-looking statements through use of words such as “may,” “will,” “can” “anticipate,” “assume,” “should,” “indicate,” “would,” “believe,” “contemplate,” “expect,” “seek,” “estimate,” “continue,” “plan,” “point to,” “project,” “predict,” “could,” “intend,” “target,” “potential,” and other similar words and expressions of the future. The Company expresses its expectations, beliefs and projections in good faith and believes that its expectations reflected in these forward-looking statements are based on reasonable assumptions. However, there is no assurance that these expectations, beliefs and projections will prove to have been correct. Such statements reflect the current views of the Company with respect to its operations and future events, and are subject to certain risks, uncertainties and assumptions relating to its proposed operations, including the risk factors set forth herein. Should one or more of these risks or uncertainties materialize or should the underlying assumptions prove incorrect, the Company’s actual results may vary significantly from those intended, anticipated, believed, estimated, expected or planned. In light of these risks, uncertainties and assumptions, any favorable forward-looking events discussed herein might not be realized and occur. The Company has no obligation to update or revise its forward-looking statements, whether as a result of new information, future events or otherwise. For a more detailed description of the risk factors and uncertainties affecting GPO Plus, Inc. GPOX, please refer to the Company’s recent Securities and Exchange Commission filings, which are available at www.sec.gov. The Company undertakes no obligation to publicly update or revise any forward-looking statements, whether as a result of new information, future events, or otherwise.

    Company Contacts:

    GPOX Shareholder Success Team:
    Brett H. Pojunis, CEO
    Email: ir@gpoplus.com
    Shareholder’s Line: 855.935.GPOX (4769)

    Liberty Ventures Team:
    Alexander McCobin, CEO
    Email: info@libertyventures.xyz

    ###

    SOURCE: GPO Plus, Inc.

    View the original press release on ACCESS Newswire

  • CEO Update: Brenmiller’s Strategic Alignment with the EU’s €1B Innovation Fund Gains Momentum

    CEO Update: Brenmiller’s Strategic Alignment with the EU’s €1B Innovation Fund Gains Momentum

    As the EU launches its €1 billion Innovation Fund to decarbonize industrial heat, Brenmiller enters as a proven, strategically aligned participant-backed by operational collaborations across Europe, a project pipeline of commercial opportunities, and real-world deployments. With key milestones, including the upcoming commissioning of our Tempo Beverages project, we continue to move from groundwork to scale-where we believe that years of focused development will convert into market traction and long-term value creation

    ROSH HA‘AYIN, IL / ACCESS Newswire / July 17, 2025 / Brenmiller Energy Ltd. (Nasdaq:BNRG)

    Dear Investors,

    Brenmiller Energy Ltd. (Nasdaq:BNRG), (the “Company” or “Brenmiller”) is not just preparing for the clean energy transition in Europe-we believe we can help promote it.

    On July 9, 2025, the European Commission formally launched the €1 billion pilot auction under the Innovation Fund (the “Fund”), marking a watershed moment in the continent’s Clean Industrial Deal (“CID”). This program targets one of the most stubborn sources of emissions-industrial process heat, which accounts for 75% of industrial CO₂ emissions, yet remains less than 4% electrified.

    This is not a course correction for Brenmiller-it’s a natural acceleration of the path we’ve spent more than a decade paving.

    A Strategy Years in the Making-Now Meeting Its Moment

    At Brenmiller, we’ve always believed thermal energy storage (“TES”) would become essential to industrial decarbonization. That belief has guided over ten years of research and development (“R&D”), system deployments, and mutually beneficial collaborations across Europe. What we’re seeing now is the market, its demand and EU policy are moving towards us.

    Our bGen™ system is already operational in Europe and directly aligned with the Innovation Fund’s strategic goals, particularly in the electrification and decarbonization of industrial process heat. Specifically, bGen™ supports:

    • Decarbonization of industrial process heat – bGen™ is purpose-built to replace fossil-fuel-based industrial heat with clean, high-temperature electric storage, directly supporting the Fund’s core mission of reducing GHG emissions in energy-intensive industries.

    • High-temperature industrial electrification – With capability to deliver process heat above 400 °C, bGen™ meets the Fund’s criteria for electrification solutions including resistance, induction, or plasma heating at industrial scale.

    • Energy storage for grid flexibility and renewables integration – bGen™ offers long-duration thermal storage that smooths demand peaks, supports grid stability, and integrates with renewables-fulfilling the Fund’s emphasis on energy storage technologies.

    • Scalable commercial readiness backed by impact metrics – Designed as a fully replicable, grid-connected system, bGen™ aligns with the Fund’s requirements for maturity, cost efficiency, scalability, and measurable GHG reductions.

    These aren’t future aspirations being pitched-they’re functional realities already operating in the field. That means that as the EU’s competitive auction process is expected to open during December 2025, Brenmiller is not positioning speculative concepts; we are entering with qualified projects, field-tested assets, and direct collaboration with major industrial players already underway.

    Execution Through Collaborations: Turning Strategy Into Scale

    As examples, over the past 24 months, Brenmiller has strategically established the infrastructure, collaborations, and pipeline to meet this moment head-on:

    • Brenmiller Europe: Through our Madrid-based Brenmiller Energy Europe S.L., we’ve built a strong local presence capable of executing EU-compliant projects with speed and flexibility.

    • Viridi Energy: Our joint venture with Viridi RE (“Viridi”) is unlocking direct access to industrial clients and financial capabilities.

    • Green Enesys: Our collaboration supports the integration of TES with green hydrogen and solar. Green Enesys Group (“Green Enesys”) core project development boost our market access. The SolWinHy Cadiz Project in Spain-selected by the European Hydrogen Bank for €25 million of funding -is expected to deliver 56 MWh of renewable heat to power e-methanol production, with full system integration powered by off-grid renewables and wastewater recycling.

    • Enel: In Italy, our system was deployed to decarbonize a natural gas facility, proving both safety and scalability under commercial, grid-connected conditions.

    • Entelios AG: As Germany’s top aggregator of flexible energy loads, Entelios AG is helping us monetize stored heat through real-time energy balancing and capacity markets.

    • Partner in Pet Food (“PPF”): One of Europe’s largest pet food manufacturers, PPF is working with Brenmiller to explore the decarbonization of its thermal processes. As a high-heat industrial energy user with multi-national operations, PPF represents the type of end-user the Fund aims to support-and a strong commercial fit for bGen™ deployment.

    • ENASCO Ltd. (“ENASCO”): In a newly signed memorandum of understanding (“MoU”), ENASCO-a leading specialist in Small Modular Reactor (“SMR”) development-has engaged with Brenmiller to co-develop bGen™-integrated TES solutions tailored for nuclear applications. The collaboration targets three potential commercial projects worth $50 million by 2030 and a long-term pipeline of up to 20 potential projects valued at $650 million. The first joint project is aimed for launching in 2027, with pilot integrations aimed at powering AI data centers.

    (For those interested in the full scope of our European collaborations, project announcements, and validation milestones, a comprehensive list of sources is available in the Sources & References section at the end of this letter)

    And while these collaborations are public, we are actively engaging with multiple major energy and industrial players-t with the aim of submitting as many projects as possible in the auction bid, coming this December 2025. The fact we already developed a significant project pipeline of commercial opportunities, is appealing to these major players -who have initiated contact with us regarding the Fund’s eligible decarbonization projects.

    Momentum in Europe, Milestones at Home

    While our European pipeline is front and center in the coming Fund submission cycle-opening December 3, 2025 – we’re also achieving key commercial validation elsewhere.

    By year end, we anticipate full commissioning our bGen™ unit at Tempo Beverages Ltd. (“Tempo”), one of Israel’s largest beverage manufacturers, the producer of Pepsi, Heineken and many additional global leading beverages. The project, backed by a grant from Israel’s Ministry of Environmental Protection, is a flagship industrial deployment that will showcase how our system seamlessly integrates with live production processes-cutting emissions, lowering energy costs, and delivering stable thermal output in real-time conditions.

    Tempo marks a turning point: from proving to scaling. It represents a concrete demonstration of how our decade-long technological foundation is translating into operating assets with repeatable value and measurable results.

    The Inflection We’ve Prepared For

    When we say Brenmiller is aligned with Europe’s decarbonization goals, we’re not offering a vision-we’re presenting evidence.

    The groundwork we’ve laid is producing results. Our systems are operational. Our projects are under way. And we believe some of the industry’s most influential players are preparing to step forward, validating not only our technology-but the central role we believe bGen™ can play in Europe’s industrial decarbonization story.

    The Fund is not a starting point. For Brenmiller, we believe it’s a catalyst to accelerate what’s already in motion.

    Thank you for your continued confidence and support. We look forward to sharing more progress as we move from submissions to selections, and from selections to scale.

    Sincerely,

    Avi Brenmiller
    CEO, Brenmiller Energy Ltd. (NASDAQ:BNRG)

    Sources and references:

    About bGen™

    bGen™ ZERO is Brenmiller’s TES system, which converts electricity into heat to power sustainable industrial processes at a price that is competitive with natural gas. The bGen™ ZERO charges by capturing low-cost electricity from renewables or the grid and stores it in crushed rocks. It then discharges steam, hot water, or hot air on demand according to customer requirements. The bGen™ ZERO also supports the development of utility-scale renewables by providing critical flexibility and grid-balancing capabilities. bGen™ ZERO was named among TIME’s Best Inventions of 2023 in the Green Energy category and won Gold in the Energy Storage and Management category at the 2025 Edison Awards.

    About Brenmiller Energy Ltd.

    Brenmiller Energy helps energy-intensive industries and power producers end their reliance on fossil fuel boilers. Brenmiller’s patented bGen™ ZERO thermal battery is a modular and scalable energy storage system that turns renewable electricity into zero-emission heat. It charges using low-cost renewable electricity and discharges a continuous supply of heat on demand and according to its customers’ needs. The most experienced thermal battery developer on the market, Brenmiller operates the world’s only gigafactory for thermal battery production and is trusted by leading multinational energy companies. For more information visit the Company’s website at https://bren-energy.com/ and follow the company on X and LinkedIn.

    Forward-Looking Statements:

    This letter contains “forward-looking statements” within the meaning of the safe harbor provisions of the Private Securities Litigation Reform Act of 1995 and other federal securities laws. Statements that are not statements of historical fact may be deemed to be forward-looking statements. For example, the Company is using forward-looking statements when discussing: the Company’s project pipeline of commercial opportunities; the Company’s belief it can help promote the clean energy transition in Europe; that the Company expects long-term value creation; that EU policy and market demand are moving towards the Company’s technology; that the Company expects its technology to enter the Fund’s auction in December 2025 with qualified projects, field-tested assets, and active collaborations; that the SolWinHy Cadiz Project is expected to deliver 56 MWh of renewable heat to power e-methanol production; that the ENASCO collaboration targets three potential commercial projects worth $50 million by 2030 and a long-term pipeline of up to 20 potential projects valued at $650 million; that the first joint project with ENASCO is aimed for launching in 2027, with pilot integrations targeting AI data centers; that the Company anticipates full commissioning of its bGen™ unit at Tempo Beverages by year end; that Tempo is expected to cut emissions, lower energy costs, and deliver stable thermal output in real-time; and that Tempo represents a turning point from proving to scaling the Company’s technology. Without limiting the generality of the foregoing, words such as “plan,” “project,” “potential,” “seek,” “may,” “will,” “expect,” “believe,” “anticipate,” “intend,” “could,” “estimate” or “continue” are intended to identify forward-looking statements. Readers are cautioned that certain important factors may affect the Company’s actual results and could cause such results to differ materially from any forward-looking statements that may be made in this letter. Factors that may affect the Company’s results include, but are not limited to: the Company’s planned level of revenues and capital expenditures; risks associated with the adequacy of existing cash resources; the demand for and market acceptance of our products; impact of competitive products and prices; product development, commercialization or technological difficulties; the success or failure of negotiations; trade, legal, social and economic risks; and political, economic and military instability in the Middle East, specifically in Israel. The forward-looking statements contained or implied in this letter are subject to other risks and uncertainties, many of which are beyond the control of the Company, including those set forth in the Risk Factors section of the Company’s Annual Report on Form 20-F for the year ended December 31, 2024 filed with the U.S. Securities and Exchange Commission (“SEC”) on March 4, 2025, which is available on the SEC’s website, www.sec.gov. The Company undertakes no obligation to update these statements for revisions or changes after the date of this release, except as required by law. References and links to websites have been provided in this letter as a convenience, and the information contained on such websites is not incorporated by reference herein.

    Contact: investors@bren-energy.com

    SOURCE: Brenmiller Energy

    View the original press release on ACCESS Newswire

  • LQR House Announces Intent to Invest in Bitmain Mining Equipment for Potential Deployment at Polaris Capital’s U.S. Bitcoin Mining Farms

    LQR House Announces Intent to Invest in Bitmain Mining Equipment for Potential Deployment at Polaris Capital’s U.S. Bitcoin Mining Farms

    Company Intends to Advance Bitcoin Treasury Strategy with Plans to Enter Mining Infrastructure for Long-Term Yield Generation

    MIAMI BEACH, FLORIDA / ACCESS Newswire / July 17, 2025 / LQR House Inc. (the “Company” or “LQR House”) (NASDAQ:YHC), a niche ecommerce platform specializing in the spirits and beverage industry, today announced that it is in advanced discussions with and intends to invest in Bitmain mining machines, which are expected to be deployed at mining farms operated by Polaris Capital in Texas.

    This anticipated investment is part of LQR House’s broader cryptocurrency treasury strategy, previously approved by the its Board of Directors, which includes gaining direct exposure to Bitcoin. The Company has already secured a Coinbase Prime account for institutional-grade custody and treasury management, which is now in place and ready to support future Bitcoin activity.

    Rather than simply purchasing Bitcoin on the open market, LQR House is exploring a mining-first approach – a strategy the Board believes could provide greater long-term upside. By owning the mining hardware, LQR House would aim to generate Bitcoin directly and retain 100% ownership of any coins mined.

    “We see mining as a more strategic and efficient way to gain exposure to Bitcoin,” said a Sean Dollinger, LQR House CEO. “It positions us to accumulate BTC at a potentially lower cost while retaining full control of the asset – without being subject to market timing or external dependencies.”

    The proposed deployment of Bitmain equipment at Polaris Capital’s mining farms in Texas would allow LQR House to leverage established infrastructure and operational expertise without having to build or operate facilities of its own.

    Anticipated advantages of this strategy include:

    • Full Coin Ownership: All mined Bitcoin would be fully retained by LQR House.

    • Lower Effective Cost: Mining may provide us Bitcoin at a more favorable cost than market purchase.

    • Compounding Yield: Unlike a one-time acquisition, mining could offer a continuous stream of Bitcoin accumulation.

    This forward-looking initiative represents a significant evolution of LQR House’s strategy – blending ecommerce innovation with potential entry into digital asset infrastructure.

    Investing in Bitmain mining equipment, as well as consummation of any agreements with Bitmain Technologies Ltd. and Polaris Capital, and other related transactions discussed above, and their terms are subject to, and contingent upon, the execution of definitive agreements and other related transaction documents by the parties, corporate approvals, customary closing conditions, and regulatory approvals, as applicable. There can be no assurances that the Company will enter into any definitive agreement with Bitmain Technologies Ltd. or Polaris Capital, invest in Bitmain Mining Equipment, such equipment will be deployed at mining farms operated by Polaris Capital, and that any transactions described above will be consummated.

    About Bitmain

    Founded in 2013 by Micree Zhan and Jihan Wu, Bitmain Technologies Ltd. is a privately held, Beijing‑based semiconductor and blockchain company. It is best known as the world’s leading designer of ASIC chips and producer of AntMiner rigs for Bitcoin mining.

    Bitmain’s hardware innovations consistently power a majority of global Bitcoin hash rate, and its mining pool platforms – Antpool and BTC.com – rank among the world’s largest. With research centers across Singapore and regional offices in major markets including the U.S., Europe, Southeast Asia, Middle East, and South America, Bitmain supports mining and blockchain infrastructure in over 100 countries.

    In recent years, Bitmain has expanded into artificial intelligence and cloud computing, delivering high-density server equipment and custom-designed AI chips, while maintaining its clear leadership in cryptocurrency mining hardware.

    Driven by a mission to shape the future of decentralized finance, Bitmain is committed to pushing the boundaries of processing power, energy efficiency, and blockchain innovation.

    About Polaris Capital

    Polaris Capital (Digital Polaris Capital Limited) is a BVI-regulated asset management firm focused on digital asset investment and blockchain infrastructure. With a mission to simplify Bitcoin mining and maximize investor returns, the company launched the Bitcoin Mining Ecosystem Fund under a Cayman Islands SPC structure. Polaris operates large-scale mining farms in Texas and manages end-to-end crypto mining operations, including miner acquisition, hosting, and fund structuring. Through a commitment to compliance, innovation, and operational excellence, Polaris Capital is building a global footprint at the forefront of digital asset mining and investment management.

    About LQR House Inc.

    LQR House intends to become a prominent force in the wine and spirits e-commerce sector, epitomized by its flagship alcohol marketplace, cwspirits.com. This platform seamlessly delivers a diverse range of emerging, premium, and luxury spirits, wines, and champagnes from esteemed retail partners like Country Wine & Spirits. Functioning as a technology-driven hub, LQR House utilizes software, data analytics, and artificial intelligence to elevate consumer experience. CWSpirits.com stands out as the go-to destination for modern, convenience-oriented shoppers, providing a curated selection of alcohol products delivered to homes across the United States. Beyond its role in an e-commerce sector, LQR House is a marketing agency with a specialized focus on the alcohol industry. The Company measures campaign success by directly correlating it with sales on CWSpirits.com, demonstrating a return on investment. Backed by an influential network of around 460 figures in the alcohol space, LQR House strategically drives traffic to CWSpirits.com, enhancing brand visibility. LQR House intends to disrupt the traditional landscape of the alcohol industry, driven by its dedication to providing an unparalleled online purchasing experience and delivering tailored marketing solutions.

    Forward-Looking Statements

    Certain statements in this announcement are forward-looking statements. These forward-looking statements involve known and unknown risks and uncertainties and are based on the Company’s current expectations and projections about future events that the Company believes may affect its financial condition, results of operations, business strategy and financial needs. Shareholders can identify these forward-looking statements by words or phrases such as “may,” “will,” “expect,” “anticipate,” “aim,” “estimate,” “intend,” “plan,” “believe,” “is/are likely to,” “potential,” “continue” or other similar expressions. Forward-looking statements contained in this press release are made only as of the date of this press release. The Company undertakes no obligation to update or revise publicly any forward-looking statements to reflect subsequent occurring events or circumstances, or changes in its expectations that arise after the date hereof, except as may be required by law. These statements are subject to uncertainties and risks including, but not limited to, the uncertainties related to market conditions, and other factors discussed in the “Risk Factors” section of the Company’s Annual Report on Form 10-K for the fiscal year ended December 31, 2024, and in other reports and documents that the Company files from time to time with the United States Securities and Exchange Commission (the “SEC”). You are urged to carefully review and consider any cautionary statements and other disclosures, including the statements made under the headings “Risk Factors”. Although the Company believes that the expectations expressed in these forward-looking statements are reasonable, it cannot assure you that such expectations will turn out to be correct, and the Company cautions investors that actual results may differ materially from the anticipated results and encourages investors to review other factors that may affect its future results described in the Company’s Annual Report on Form 10-K for the fiscal year ended December 31, 2024, and in other reports and documents that the Company files from time to time with the SEC. Additional factors are discussed in the Company’s filings with the SEC, which are available for review at www.sec.gov. References and links to websites have been provided as a convenience, and the information contained on such websites has not been incorporated by reference into this press release.

    Investor and Media Contact:
    info@lqrhouse.com

    SOURCE: LQR House

    View the original press release on ACCESS Newswire

  • 4-Star Electric Wins 2025 Consumer Choice Award for Electrical Contractors in Southern Alberta

    4-Star Electric Wins 2025 Consumer Choice Award for Electrical Contractors in Southern Alberta

    Calgary’s trusted family-owned electrical company recognized for outstanding service, safety, and customer satisfaction.

    CALGARY, ALBERTA / ACCESS Newswire / July 17, 2025 / 4-Star Electric Ltd., Calgary’s most trusted family-owned electrical service provider, has won the 2025 Consumer Choice Award in the Electrical Contractors category for Southern Alberta. This recognition celebrates more than 35 years of dedication to delivering safe, expert electrical solutions and outstanding service that feels like family care.

    Founded by John and Irene Vannus in 1989 right out of their family home, 4-Star Electric has grown into Calgary and area’s most chosen electrical partner – proudly serving homeowners, businesses, and contractors with a commitment to brighten lives, one project at a time.

    A Legacy That Shines Bright
    When John and Irene started 4-Star Electric, they wanted more than a company; they wanted a family legacy built on trust and excellent work. The name itself is a nod to their four sons – Denny, Dustin, Denver, and Dallas – two of whom now help lead the company forward. Back in the ‘80s, four stars was the highest possible service rating, and today, the Vannus family continues to live up to that promise with each satisfied customer.

    “Winning the Consumer Choice Award means so much to us because it comes directly from the trust our customers place in our family and team,” said John and Irene Vannus, Co-Founders of 4-Star Electric. “Our mission has always been to provide timely, trustworthy service with care and integrity – treating every customer like part of our own family.”

    Your Trusted Electrical Partner
    4-Star Electric handles projects big and small, from fixing flickering lights in a family home to complex electrical upgrades for businesses and new builds. Their range of services includes:

    • Residential Electrical Services: Inspections, repairs, panel upgrades, surge protection, lighting installations, and whole-home safety checks.

    • Commercial Electrical Solutions: Code compliance, tenant improvements, energy-saving retrofits, and routine maintenance for businesses.

    • Emergency Electrical Services: 24/7 fast response for urgent electrical issues to keep families and businesses safe.

    • Specialty Services: Underground repairs, aluminum wiring replacement, electric vehicle charging stations, smoke detector installation, and more.

    Customers appreciate clear, upfront pricing with no surprises – a cornerstone of the company’s commitment to honesty and transparency.

    Service with Heart and Skill
    What sets 4-Star Electric apart is its warm, family-centered culture paired with best-in-class technical expertise. Each licensed electrician undergoes continuous training on the latest techniques and codes to ensure that every job meets or exceeds industry standards.

    Their courteous, uniformed professionals arrive on time, respect each property like their own, and never consider the job done until the customer is 100% satisfied.

    Rooted in Community Trust
    With more than 1,100 glowing Google reviews and decades of repeat business, 4-Star Electric’s reputation speaks for itself. Word-of-mouth referrals have powered the company’s steady growth, as generations of Calgary families and businesses choose them again and again.

    For the Vannus family, the real reward has always been the relationships they build – and the peace of mind they deliver every time they flip the switch.

    Continuing to Raise the Standard
    With this Consumer Choice Award, 4-Star Electric looks ahead with plans to keep investing in staff training, adopt energy-efficient solutions, and embrace new technologies to better serve Southern Alberta. One thing will never change: the promise to treat every customer with the same care and respect that built their legacy from a kitchen table to Calgary’s trusted name in electrical work.

    To learn more about 4-Star Electric’s award-winning services or to request an appointment, CLICK HERE or visit www.4starelectric.com.

    About Consumer Choice Award:
    Consumer Choice Award has been recognizing and promoting business excellence in North America since 1987. Its rigorous selection process ensures that only the most outstanding service providers in each category earn this prestigious recognition. Visit www.ccaward.com to learn more.

    Contact Information:
    Sumi Saleh
    Communications Manager
    ssaleh@ccaward.com

    SOURCE: Consumer Choice Award

    View the original press release on ACCESS Newswire

  • Kingbird Ventures Files Legal Action Against LQR House Inc. Seeking Court-Appointed Receiver

    Kingbird Ventures Files Legal Action Against LQR House Inc. Seeking Court-Appointed Receiver

    MIAMI BEACH, FLORIDA / ACCESS Newswire / July 17, 2025 / Kingbird Ventures, LLC, an affiliate of Diveroli Investment Group (DIG), has filed a complaint in the Eighth Judicial District Court of Nevada, requesting the appointment of a court-supervised receiver to oversee operations at LQR House Inc. (YHC). The goal, according to Kingbird, is to ensure proper governance and protect the interests of all shareholders.

    “We are seeking to marshal all corporate assets for the benefit of shareholders and believe this action was necessary to restore order and transparency,” said Efraim Diveroli, Strategic Advisor to Diveroli Investment Group. “We believe our complaint is well-plead and encourage the public to read it and draw their own conclusions.”

    The announcement follows recent speculation on social media regarding Kingbird’s identity, after some observers mistakenly linked the firm to a recent Schedule 13D filed by Robert Leshner, who has expressed interest in helping LQR House explore new strategies.

    Leshner, who is a prominent figure in the fintech and crypto sectors, indicated plans to replace YHC’s current board and explore strategic alternatives. The move appears to have been widely viewed by investors as a credible effort to unlock value and sparked renewed optimism about the company’s future direction.

    “We believe this is a start of a new chapter,” said Diveroli. “And with the right leadership, LQR House shareholders could be primed for long-term value.”

    About Diveroli Investment Group

    Diveroli Investment Group (or “DIG”) is a Miami based family-run investment firm that pursues value creation through opportunities in public and private companies. The firm focuses on sectors where technological change, operational inflection points, or strategic under-appreciation create significant upside potential.

    To learn more about Diveroli Investment Group’s investment philosophy and current areas of focus, please visit: www.investdig.com

    Investor & Media Relations
    Avigail Diveroli, Communications Director
    Diveroli Investment Group
    Email: avigail@investdig.com
    Website: www.investdig.com

    SOURCE: Diveroli Investment Group

    View the original press release on ACCESS Newswire

  • The Spider Guys Recognized for Superior Service with 2025 Consumer Choice Award in Pest Control for Windsor

    The Spider Guys Recognized for Superior Service with 2025 Consumer Choice Award in Pest Control for Windsor

    WINDSOR, ON / ACCESS Newswire / July 17, 2025 / The region’s trusted defenders against unwanted intruders have officially earned top honours. The Spider Guys have been named the 2025 Consumer Choice Award Winner in the Pest Control category for Windsor, celebrating the company’s customer-first approach, effective treatments, and innovative year-round protection plans.

    Proudly serving Windsor through to Chatham-Kent and the surrounding areas, The Spider Guys have built a strong reputation for offering reliable, efficient pest control solutions that homeowners trust. With years of experience in both structural and outdoor pest management, the company has become the go-to name for those seeking dependable, stress-free service.

    “We’re incredibly proud to receive Consumer Choice Award for 2025,” said the team at The Spider Guys. “It’s a reflection of the trust our customers place in us, and our promise to always deliver pest control solutions that are not only effective, but affordable, hassle-free, and guaranteed.”

    A Simpler Way to Stay Pest-Free
    The Spider Guys are leading the charge in a new era of pest control-one that prioritizes prevention, convenience, and customer satisfaction. Their subscription-based pest control plans offer year-round peace of mind, allowing homeowners to “set it and forget it” while maintaining pest-free homes and yards.

    Their services cover a full range of pest issues, including:

    • Spiders and crawling insects

    • Ants, earwigs, and centipedes

    • Wasps and hornets

    • Mice and rodent prevention

    • Perimeter treatments for homes and yards

    With flexible plans and a 100% satisfaction guarantee, The Spider Guys eliminate the guesswork and stress often associated with seasonal infestations. By offering consistent maintenance at affordable rates, they help homeowners protect their investments without lifting a finger.

    Local Roots, Big Impact
    What began as a focused service provider with a mission to bring honest, effective pest control to Windsor has quickly grown into a community favourite. The Spider Guys are known for their approachable team, clear communication, and integrity-driven service. Every technician is trained to not only treat the issue but also educate clients about prevention and long-term protection.

    From quaint suburban homes to rural properties and multi-acre estates, The Spider Guys treat every project with the same level of care and professionalism. Their local knowledge, combined with deep industry experience, gives them a unique edge in identifying and treating pests specific to the region’s seasonal patterns.

    Consumer Choice Recognition Built on Trust
    Consumer Choice Award is the only organization in North America to recognize business excellence through a statistically supported, independent market research process. Using a proprietary four-step methodology, winners are chosen based on brand reputation, presence on verified review platforms, and marketplace awareness. Only one company per category, per region is selected-making this a truly distinguished honour.

    For The Spider Guys, this award affirms what customers across Windsor already know: they offer some of the most dependable and innovative pest control services in the region.

    Looking Ahead: Pest-Free Living Made Even Easier
    As the company looks to the future, The Spider Guys plan to continue expanding their subscription offerings, adding smart technology integrations and new environmentally conscious treatment options. Their focus remains clear: provide easy, effective solutions that empower homeowners to enjoy their spaces without worry.

    Whether dealing with an ongoing issue or proactively protecting a home year-round, customers can count on The Spider Guys to be professional, punctual, and proactive.

    To learn more about The Spider Guys or to sign up for a pest control plan, CLICK HERE or visit www.thespiderguys.com.

    About Consumer Choice Award:
    Consumer Choice Award has been recognizing and promoting business excellence in North America since 1987. Its rigorous selection process ensures that only the most outstanding service providers in each category earn this prestigious recognition. Visit www.ccaward.com to learn more.

    Contact Information:
    Sumi Saleh
    Communications Manager
    ssaleh@ccaward.com

    SOURCE: Consumer Choice Award

    View the original press release on ACCESS Newswire

  • Principled Craftsmanship, Trusted Results: Principal Roofing & Exterior Contractors Wins 2025 Consumer Choice Award in York Region

    Principled Craftsmanship, Trusted Results: Principal Roofing & Exterior Contractors Wins 2025 Consumer Choice Award in York Region

    AURORA, ON / ACCESS Newswire / July 17, 2025 / Principal Roofing & Exterior Contractors, a standout name in the roofing and exterior contracting space, has earned the 2025 Consumer Choice Award in the Roofing category in York Region. This recognition highlights the company’s strong reputation for craftsmanship, integrity, and long-term customer relationships across both residential and commercial sectors.

    With years of hands-on experience and a team of certified professionals, Principal Roofing has built a legacy rooted in precision, professionalism, and responsiveness. The company is widely recognized for its clear communication, high-calibre materials, and consistent delivery of roofing systems that are built to last-even in Canada’s most challenging weather conditions.

    “It’s incredibly meaningful to receive this recognition,” said Sara Prince, President of Principal Roofing & Exterior Contractors. “Our entire team is committed to doing things the right way-from the first consultation to the final cleanup. Being honoured in our home region is a proud moment for us, and a reflection of the trust we’ve worked hard to earn.”

    A Roofing Partner with a Purpose
    Principal Roofing offers a full spectrum of services designed to protect and elevate the value of homes and buildings throughout York Region. From comprehensive roof replacements and flat roofing systems to eavestrough, soffit, and fascia installations, the company approaches every project with a commitment to reliability, safety, and long-term performance.

    Its process prioritizes transparency and convenience, providing customers with clear timelines, detailed estimates, and skilled workmanship backed by robust warranties. Whether it’s a small repair or a complete roofing system overhaul, the team works closely with clients to ensure a stress-free experience with lasting results.

    Core services include:

    • Asphalt and flat roofing installations

    • Roof repairs and preventative maintenance

    • Eavestrough, soffit, and fascia services

    • Leak detection and emergency repair response

    • Residential and commercial project execution

    Built on Relationships, Not Just Roofs
    At the heart of Principal Roofing’s approach is a belief in treating every property as if it were their own. The company has cultivated a strong local reputation by prioritizing respect, responsiveness, and consistent quality.

    “Our work is a direct reflection of who we are,” added Prince. “We’re not just fixing roofs-we’re building trust, one job at a time. Our clients deserve transparency, craftsmanship, and peace of mind, and that’s exactly what we aim to deliver.”

    Recognition Through Community Support
    The Consumer Choice Award is based on in-depth market research, customer feedback, and brand reputation. For Principal Roofing, the award is a meaningful endorsement from the York Region community-an acknowledgment of the company’s efforts to consistently exceed expectations in a competitive industry.

    As demand for reliable roofing and exterior services continues to rise across the region, Principal Roofing is well-positioned for continued growth. The company plans to invest further in its workforce, technology, and customer experience-ensuring it stays ahead of evolving client needs.

    “Our future is rooted in the same values that brought us here: quality, accountability, and respect for every client,” said Prince. “We’re proud of this achievement, and even more excited for what’s ahead.”

    To learn more about Principal Roofing & Exterior Contractors, CLICK HERE or visit www.principalroofing.ca.

    About Consumer Choice Award:
    Consumer Choice Award has been recognizing and promoting business excellence in North America since 1987. Its rigorous selection process ensures that only the most outstanding service providers in each category earn this prestigious recognition. Visit www.ccaward.com to learn more.

    Contact Information:
    Sumi Saleh
    Communications Manager
    ssaleh@ccaward.com

    SOURCE: Consumer Choice Award

    View the original press release on ACCESS Newswire

  • Cerrado Gold Announces Q2 2025 Production Results at Its Minera Don Nicolas Mine in Argentina

    Cerrado Gold Announces Q2 2025 Production Results at Its Minera Don Nicolas Mine in Argentina

    • Gold Equivalent Ounce (“GEO”) Production of 11,437 GEO for the 2nd Quarter 2025

    • Underground Development has commenced and production set to ramp up in H2/2025

    • Expanded crushing and agglomeration capacity should expand tonnages to the leach pads and improve recoveries at the Heap Leach operation

    • 2025 Production Guidance of 55,000 – 60,000 GEO remains in place, production weighted to H2 2025 as underground ramps up

    • 20,000m Exploration Program underway at MDN targeting potential significant resource growth opportunities

    • Development activities continue to progress both the Lagoa Salgada and Mont Sorcier projects

    TORONTO, ONTARIO / ACCESS Newswire / July 17, 2025 / Cerrado Gold Inc. (TSXV:CERT)(OTCQX:CRDOF) (“Cerrado” or the “Company”) announces production results for the second quarter ended June 2025 (“Q2 2025”) from the Minera Don Nicolas Mine in Santa Cruz Province, Argentina (“MDN”). Full quarterly financial results are expected to be released prior to August 30, 2025.

    Q2 Operating Highlights

    • Q2 Production of 11,437 GEO vs 11,163 in Q1

    • Heap leach production steadily ramping up to expanded capacity for H2/25

    • Underground development at Paloma commencing as planned with three access portals started

    • CIL plant starting to receive initial contribution from underground development, production expected to ramp up over H2/2025

    Operational results for Q2 2025 showed a slight increase in production over the previous quarter, driven by modestly higher production from the heap leach operations. The heap leach operational performance remained steady over the quarter, however, recovery rates were impacted by a larger amount of primary ore placed on the pad during the quarter due to mine sequencing. This primary material has lower recovery rates and longer retention times as compared to oxide material. Heap leach production is expected to improve in H2/25 as more oxide ore is mined, the addition of an agglomerator to reduce fines and the ongoing upgrades to the crushing circuit are completed. In addition, during the quarter the crushing circuit was offline for approximately 15 days early in the quarter as upgrades were put in place to support higher throughput rates moving forward. Production from stockpiled material via the CIL plant declined somewhat due to lower grades, however, underground operations at Paloma are expected to begin to contribute meaningfully to production in Q3 2025 and beyond as development rates increase and more ore becomes available.

    The second phase of the expansion of the heap leach crushing circuit is now operational, which will increase feed stability in order to deliver steady ore to the pad. While supporting higher production rates, additional crushing facilities are also expected to reduce the feed size to the pad and result in increased recoveries. The final updates to the crusher circuit, including final installation of the agglomerator and additional conveyors, are set to be completed in Q3/25

    As previously announced, the company commenced underground mining in June, opening up three portals for underground mining beneath the Paloma pit. Ore production is expected to ramp up over the coming months and is set to make a material contribution to production rates as the year progresses. While initial production expectations are relatively modest given the current known underground resource, underground access is expected to provide a platform for major exploration activities at lower costs than drilling from surface. Underground exploration aims to materially expand resources at MDN, leveraging the underground development for a potential expansion in production and/or mine life.

    On the exploration front, the Company commenced an approximate 20,000 metre drill program late in the quarter and is set to drill numerous targets in the coming months with the aim to potentially define new resources to provide mill feed to the CIL plant at MDN. Drilling commenced with a single DDH rig north of the Paloma pit, where several new veins have been intersected. Results are pending and further drilling will be required to confirm any new resources.

    Mark Brennan, CEO and Chairman commented, “While Q2 results were modestly lower than our expectations as the heap leach continues to ramp up to its fully expanded capacity, we continue to be confident in our full year expectations as the underground operations ramp-up in H2/25. Cerrado also continued to progress both the Lagoa Salgada project and the Mont Sorcier projects towards completion of feasibility studies by Q3/2025 and Q1/2026 respectively, which we believe should demonstrate substantial value being unlocked by Cerrado’s development projects.”

    Mont Sorcier Project Update

    At the Mont Sorcier high-purity iron project, detailed metallurgical test work and flow sheet design continued during the quarter. All key workstreams are now engaged and the Company has commenced an infill drill program to update sufficient resources to the Proven and Probable categories as required to support the ongoing feasibility. Assay results remain pending at this time.

    The Bankable Feasibility Study will look to provide greater detail of the potential for the project that was highlighted in the previous 2022 NI 43-101 Preliminary Economic Assessment (“PEA”) that delivered a project NPV8% of US$1.6 Billion based upon iron concentrates grading 65% iron. With the improved metallurgical results received to date the Company is confident it can deliver a high purity DRI grade Iron ore concentrate product of over 67% iron, enhancing the project value and delivering a highly desired product to support the Green Steel transition.

    Lagoa Salgada Project Update

    At the Lagoa Salgada polymetallic VMS project, detailed metallurgical test work is scheduled to be completed by the end of July, with results targeting improvements across recoveries and grades for the various concentrate products. An updated Mineral Resource and Reserve Estimate is planned to be completed in Q3/25 incorporating the results of the metallurgical test work as well as using updated long term commodity price expectations. This updated resource will be used as part of the Optimized Feasibility Study that is well underway and expected to be completed around the end of Q3/25.

    Corporate Activities

    In addition to funding development programs at Lagoa Salgada and Mont Sorcier Cerrado continued to pay down debt during the quarter. The Company anticipates its balance sheet to strengthen over the remainder of the year as cash flow increases from higher production rates and strong gold prices. In the medium term the Company is also set to receive future payments from the sale of the Brazilian Monte do Carmo asset sale totaling US$15 million (U$10 million due in July 2026 and US$5 million by March 2027) as well as a further US$10 million should the option granted over the Company’s Michelle properties in Argentina be exercised.

    Table 1. Key Operating Information

    Review of Technical Information

    The scientific and technical information in this press release has been reviewed and approved by Andrew Croal, P.Eng., Chief Technical Officer for Cerrado Gold, who is a Qualified Person as defined in National Instrument 43-101.

    About Cerrado

    Cerrado Gold is a Toronto-based gold production, development, and exploration company. The Company is the 100% owner of the producing Minera Don Nicolás and Las Calandrias mine in Santa Cruz province, Argentina. In Portugal, the Company holds an 80% interest in the highly prospective Lagoa Salgada VMS project through its position in Redcorp – Empreendimentos Mineiros, Lda. In Canada, Cerrado Gold is developing its 100% owned Mont Sorcier Iron project located outside of Chibougamou, Quebec.

    In Argentina, Cerrado is maximizing asset value at its Minera Don Nicolas (“MDN”) operation through continued operational optimization and is growing production through its operations at the Las Calandrias heap leach project. An extensive campaign of exploration is ongoing to further unlock potential resources in our highly prospective land package in the heart of the Deseado Masiff.

    In Portugal, Cerrado is focused on the development and exploration of the highly prospective Lagoa Salgada VMS project located on the prolific Iberian Pyrite Belt in Portugal. The Lagoa Salgada project is a high-grade polymetallic project, demonstrating a typical mineralization endowment of zinc, copper, lead, tin, silver, and gold. Extensive exploration upside potential lies both near deposit and at prospective step-out targets across the large 7,209-hectare property concession. Located just 80km from Lisbon and surrounded by exceptional infrastructure, Lagoa Salgada offers a low-cost entry to a significant development and exploration opportunity, already showing its mineable scale and cashflow generation potential.

    In Canada, Cerrado holds a 100% interest in the Mont Sorcier high purity high grade DRI Iron project, which has the potential to produce a premium iron concentrate over a long mine life at low operating costs and low capital intensity. Furthermore, its high grade and high purity product facilitates the migration of steel producers from blast furnaces to electric arc furnaces, contributing to the decarbonization of the industry and the achievement of sustainable development goals.

    For more information about Cerrado please visit our website at: www.cerradogold.com.

    Mark Brennan
    CEO and Chairman

    Mike McAllister
    Vice President, Investor Relations
    Tel: +1-647-805-5662
    mmcallister@cerradogold.com

    Disclaimer

    NEITHER TSX VENTURE EXCHANGE NOR ITS REGULATION SERVICES PROVIDER (AS THAT TERM IS DEFINED IN THE POLICIES OF THE TSX VENTURE EXCHANGE) ACCEPTS RESPONSIBILITY FOR THE ADEQUACY OR ACCURACY OF THIS RELEASE.

    This press release contains statements that constitute “forward-looking information” (collectively, “forward-looking statements”) within the meaning of the applicable Canadian securities legislation. All statements, other than statements of historical fact, are forward-looking statements and are based on expectations, estimates and projections as at the date of this news release. Any statement that discusses predictions, expectations, beliefs, plans, projections, objectives, assumptions, future events or performance (often but not always using phrases such as “expects”, or “does not expect”, “is expected”, “anticipates” or “does not anticipate”, “plans”, “budget”, “scheduled”, “forecasts”, “estimates”, “believes” or “intends” or variations of such words and phrases or stating that certain actions, events or results “may” or “could”, “would”, “might” or “will” be taken to occur or be achieved) are not statements of historical fact and may be forward-looking statements.

    Forward-looking statements contained in this press release include, without limitation, statements regarding the business and operations of Cerrado, production forecasts and estimated AISC for 2025 and beyond, the potential for additional crushing capacity that may be added and the performance of the heap leach pad, the production potential of MDN’ underground mining operations, the potential to produce iron concentrate grading in excess of 67% at Mont Sorcier and the potential to enhance project value, anticipated timing to complete metallurgical test work at Lagoa Salgada, the potential further deleveraging and/or the potential to enhance liquidity during 2025, receipt of the deferred closing payment of US$15 million in connection with the Monte do Carmo asset sale, the likelihood of the Michelle option being exercised by the optionor and the related option payment being received. In making the forward-looking statements contained in this press release, Cerrado has made certain assumptions. Although Cerrado believes that the expectations reflected in forward-looking statements are reasonable, it can give no assurance that the expectations of any forward-looking statements will prove to be correct. Known and unknown risks, uncertainties, and other factors which may cause the actual results and future events to differ materially from those expressed or implied by such forward-looking statements. Such factors include, but are not limited to general business, economic, competitive, political and social uncertainties. Accordingly, readers should not place undue reliance on the forward-looking statements and information contained in this press release. Except as required by law, Cerrado disclaims any intention and assumes no obligation to update or revise any forward-looking statements to reflect actual results, whether as a result of new information, future events, changes in assumptions, changes in factors affecting such forward-looking statements or otherwise.

    SOURCE: Cerrado Gold Inc.

    View the original press release on ACCESS Newswire